Related Experiment Video
Updated: Mar 6, 2026

Isolation and Genome Analysis of Single Virions using 'Single Virus Genomics'
Published on: May 26, 2013
The isolation and characterization of Stenotrophomonas maltophilia T4-like bacteriophage DLP6
Danielle L Peters1, Paul Stothard2, Jonathan J Dennis1
16-065 Centennial Centre for Interdisciplinary Science, Department of Biological Sciences, University of Alberta, Edmonton, Alberta, Canada.
Abstract:
Increasing isolation of the extremely antibiotic resistant bacterium Stenotrophomonas maltophilia has caused alarm worldwide due to the limited treatment options available. A potential treatment option for fighting this bacterium is 'phage therapy', the clinical application of bacteriophages to selectively kill bacteria. Bacteriophage DLP6 (vB_SmoM-DLP6) was isolated from a soil sample using clinical isolate S. maltophilia strain D1571 as host. Host range analysis of phage DLP6 against 27 clinical S. maltophilia isolates shows successful infection and lysis in 13 of the 27 isolates tested. Transmission electron microscopy of DLP6 indicates that it is a member of the Myoviridae family. Complete genome sequencing and analysis of DLP6 reveals its richly recombined evolutionary history, featuring a core of both T4-like and cyanophage genes, which suggests that it is a member of the T4-superfamily. Unlike other T4-superfamily phages however, DLP6 features a transposase and ends with 229 bp direct terminal repeats. The isolation of this bacteriophage is an exciting discovery due to the divergent nature of DLP6 in relation to the T4-superfamily of phages.
Insights
Researchers isolated a novel bacteriophage, DLP6, effective against the antibiotic-resistant bacterium Stenotrophomonas maltophilia. This discovery offers a promising new avenue for phage therapy in combating difficult-to-treat bacterial infections.
Area of Science:
- Microbiology
- Bacteriology
- Virology
Background:
- Antibiotic resistance in Stenotrophomonas maltophilia presents a global health challenge.
- Limited treatment options necessitate alternative therapeutic strategies.
- Phage therapy, using bacteriophages to target bacteria, is a potential solution.
Purpose of the Study:
- To isolate and characterize a bacteriophage capable of infecting and lysing Stenotrophomonas maltophilia.
- To investigate the genetic makeup and evolutionary history of the isolated bacteriophage.
Main Methods:
- Isolation of bacteriophage DLP6 from a soil sample using S. maltophilia as the host.
- Host range analysis against 27 clinical S. maltophilia isolates.
- Transmission electron microscopy for morphological characterization.
- Whole-genome sequencing and bioinformatic analysis.
Main Results:
- Bacteriophage DLP6 was successfully isolated and demonstrated lytic activity against 13 out of 27 clinical S. maltophilia isolates.
- Transmission electron microscopy classified DLP6 as a member of the Myoviridae family.
- Genome analysis revealed DLP6 belongs to the T4-superfamily, with unique features including a transposase and direct terminal repeats.
Conclusions:
- Bacteriophage DLP6 is a novel agent with potential for treating Stenotrophomonas maltophilia infections.
- The unique genetic composition of DLP6 provides insights into phage evolution.
- This discovery advances the field of phage therapy for multidrug-resistant bacteria.
More Related Videos
Related Concept Videos
DNA Bacteriophages
Viral Replication: Lytic Cycle
Lytic Cycle of Bacteriophages

